CTLA4 and Merkel cell skin cancer: The randomized, multicenter DeCOG/AGO study (NCT02196961) of ipilimumab, an human monoclonal antibody against the cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), versus observation after complete resection of primary or locoregional metastatic MCC enrolled 40 patients [96].